SFS
MDGL icon

Sowell Financial Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Sowell Financial Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-180
Closed -$23K – 1826
2021
Q1 		$23K Sell
180
-4
-2% -$466 ﹤0.01% 1999
2020
Q4 		$20K Buy
184
+64
+53% +$7.82K ﹤0.01% 1748
2020
Q3 		$14K Sell
120
-36
-23% -$3.91K ﹤0.01% 1698
2020
Q2 		$18K Sell
156
-300
-66% -$29.5K ﹤0.01% 1499
2020
Q1 		$30K Sell
456
-255
-36% -$21.2K ﹤0.01% 1243
2019
Q4 		$65K Buy
711
+611
+611% +$59.3K 0.01% 1058
2019
Q3 		$9K Buy
+100
New +$9.38K ﹤0.01% 1566

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Sowell Financial Services's MDGL Position: Q2 2021 in Review

Sowell Financial Services sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2021, closing a stake of 180 shares — an estimated $23K sold.

Sowell Financial Services first reported a position in MDGL in Q3 2019 and held it in 7 quarters. The position peaked at $65K in Q4 2019. 151 funds tracked by Wall St. Rank hold MDGL as of Q2 2021.

  • Sowell Financial Services reported no remaining Madrigal Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 180 Madrigal Pharmaceuticals shares in Q2 2021, an estimated $23K.
  • Sowell Financial Services first reported a position in Madrigal Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Madrigal Pharmaceuticals position peaked at $65K in Q4 2019.
  • 151 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.